http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3613419-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4d87576b96258c7f9bcb560c34679dda |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-306 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-40 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-10 |
| filingDate | 2018-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de7bf9222ad580540613e2f82e6df8fc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9cbcf4509e01ddc0b210c70ec15e022 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6cf9faeb7a4640552dfb2ba29657e5c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ae1a51fd1421ac10251998c35823b5e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd55e251236e33b4984bbf7013d690d8 |
| publicationDate | 2020-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-3613419-A1 |
| titleOfInvention | Pharmaceutical composition containing indirubin derivative as active ingredient |
| abstract | A composition for promoting longitudinal bone growth, according to the present invention, promotes the proliferation of the chondrocytes and the differentiation of the osteoblasts and has effects of simultaneously increasing longitudinal bone length and thickness (bone density), and thus has an advantage of being widely prescribable to various age groups, thereby being usable as a pharmaceutical composition for promoting the growth of longitudinal bone length and thickness. An indirubin derivative according to the present invention has prevention or treatment effects through oral administration and has an excellent competitive price unlike conventional hormone-based therapeutic agents. In addition, unlike conventional therapeutic agents, the pharmaceutical composition for preventing or treating bone diseases of the present invention is a stable compound, which is known to be substantially noncytotoxic to the human body, and is a material of which adverse effects have not been identified and which has excellent treatment effects for bone diseases and osteogenesis imperfecta. |
| priorityDate | 2017-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 127.